SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 11.44.
| Share Price | ₹542.2 | Dec 05,2025 |
| Market Cap | ₹20,744.6 Cr | |
| Sales-TTM | ₹1,814.1 Cr | TTM-Consolidated Results |
| Price/Sales | 11.44x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,744.6 Cr] as on Dec 05,2025
(/) Sales [ ₹1,814.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.44x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '11.44 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.89x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 12.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 24.66x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 8.98x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN PHARMACEUTICALS | 1,814.1 | 11.44 | 20,744.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.88 | 433,068.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.14 | 171,847.0 |
| CIPLA LTD | 28,349.6 | 4.33 | 122,826.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.45 | 127,985.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.10 | 106,418.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.70 | 91,011.1 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.83 | 93,725.7 |
| LUPIN LTD | 24,750.7 | 3.87 | 95,812.7 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.17 | 70,709.7 |
| ABBOTT INDIA LTD | 6,714.4 | 9.14 | 61,345.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.17x |
| Max industry PS | 17.14x |
| Median industry PS | 6.70x |
| Average industry PS | 7.28x |
You may also like the below Video Courses